Search Results - "Fontanet, M."

CAN THE ETHICAL DILEMMAS FOR HEALTH CARE DECISION MAKING ON DRUG REIMBURSMENT BE TACKLED THROUGH HOLISTIC MCDA: AN ADAPTATION OF THE EVIDEM FRAMEWORK IN REAL-WORLD SETTING - THE CATALAN EXPERIENCE by Badia, X, Khoury, H, Merino-Montero, S, Fontanet, M, Torrent-Farnell, J, Catalan, A, Prat, A, Gilabert Perramon, A, Goetghebeur, M.M

Get full text

Residual vibration reduction in back-and-forth moving systems driven by slider-crank mechanisms working through a dead point configuration by Veciana Fontanet, Joaquim M., Jordi Nebot, Lluïsa, Lores Garcia, Eduard

“…•Residual vibrations reduction of a system driven through a linkage mechanism.•Oscillatory system moved through a linkage mechanism at a dead point…”
Get full text

HPR152 Evolution of the Use of Medicines in Special Situations and Management Measures for Their Rational Use by Paco, N., Gasol, M., Rosich, L., Caballería, P., Fontanet, M., Vallano Ferraz, A., Pontes, C.

Get full text

The value of satellite remote sensing soil moisture data and the DISPATCH algorithm in irrigation fields by Fontanet, Mireia, Fernàndez-Garcia, Daniel, Ferrer, Francesc

“…Soil moisture measurements are needed in a large number of applications such as hydro-climate approaches, watershed water balance management and irrigation…”
Get full text

HTA8 The Catalan Health Service, An Example Where Patients Have Full Medicine Appraisal and Decision-Making Representation by Gasol, M, Fontanet, M, Guarga, L, de Maria, A, Castillo, C, Ramirez, S, Aguado, M, Porro, A

Get full text

Feasibility of motion laws for planar one degree of freedom linkage mechanisms at dead point configurations by Lores García, E., Veciana Fontanet, J.M., Jordi Nebot, L.

“…•The continuity condition of a motion law is analyzed at dead point configurations.•The feasibility of the laws is imposed to be reproduced by electrical…”
Get full text

HPR144 Support of RWE in the Price and Reimbursement Decision-Making Process for Rare Diseases in Spain by De La Paz Cañizares, I., Saborido, C., Fontanet, M., Calleja, MÁ, Martínez-Sesmero, J.M., Sala Piñol, F., Asensio, I., Hernaez Colque, M., Ferrandez, O., Castillo, C.

Get full text

Using HYDRUS-1D for estimating evapotranspiration and soil water content of irrigated winter wheat under different water management in a semi-arid region of Morocco by Er-Raki, S., Ezzahar, J., Anbari, C., Amazirh, A., Ait Hssaine, B., Khabba, S., Fontanet, M., Merlin, O., Chehbouni, A.

Get full text

PSY49 - BUDGETARY IMPACT OF ORPHAN DRUGS IN THE CATALAN HEALTHCARE SERVICE by Fontanet, M., Obach, M., Pastor, M., Gasol, M., Guarga, L., Delgadillo, J., Pontes, C., Torrent, J.

Get full text

PHP129 - Development Of An Specific Evaluation Framework For Orphan Drugs Based On Multi-Criteria Decision Analysis (MCDA) For Health Care Decision Making In Catalonia by Badia, X, Pontes, C, Fontanet, M, Obach, M, Vallano, A, Torrent, J, Guarga, L

Get full text

Development Of An Specific Evaluation Framework For Orphan Drugs Based On Multi-Criteria Decision Analysis (MCDA) For Health Care Decision Making In Catalonia by Badia, X, Pontes, C, Fontanet, M, Obach, M, Vallano, A, Torrent, J, Guarga, L

“…OBJECTIVES: To develop a Multi-Criteria Decision Analysis (MCDA) framework specific for Orphan Drugs (OD) in Catalonia, aimed to facilitate and homogenize the…”
Get full text

PHP23 - COMPARING RISK SHARING AGREEMENTS IN CATALONIA WITH OTHERS EU COUNTRIES by Guarga, L., Fondevilla, E., Pastor, M., Roig, M., Cirera, J., Llop, C., Alonso, E., Obach, M., Fontanet, M., Gasol, M., Zara, C., Pontes, C., Delgadillo, J.

Get full text

HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision-Making in Catalonia (Spain): Pilot Study Focused in Orphan Drugs by Gilabert-Perramon, A, Torrent-Farnell, J, Catalan, A, Prat, A, Fontanet, M, Puig-Peiró, R, Merino-Montero, S, Khoury, H, Goetghebeur, MM, Badia, X

Get full text

PHP34 - CAN THE ETHICAL DILEMMAS FOR HEALTH CARE DECISION MAKING ON DRUG REIMBURSMENT BE TACKLED THROUGH HOLISTIC MCDA: AN ADAPTATION OF THE EVIDEM FRAMEWORK IN REAL-WORLD SETTING - THE CATALAN EXPERIENCE by Badia, X., Khoury, H., Merino-Montero, S., Fontanet, M., Torrent-Farnell, J., Catalan, A., Prat, A., Gilabert Perramon, A., Goetghebeur, M.M.

Get full text

1628OConsistency of ESMO-MCBS scores with drug access recommendations in Catalonia by Salazar, C, Obach, M, Fontanet, J M, Garrido, G, Feliu, A, Riba, M, Umbria, M, Gasol, M, Prat, A, Vallano, A, Pontes, C

“…Abstract Background The Catalan Healthcare System (CatSalut) runs a specific program for drug evaluation (PHF) aimed to guarantee equity in the access to…”
Get full text

Efectividad del uso de cefuroxima intracameral como profilaxis en la cirugía de cataratas by Fontanet, J.M., March, F., Morón, A., Gorgas, M.Q.

Get full text

High frequency of HTLV-1 infection in Bantus and Pygmies from rural Cameroon bitten by non-human primates during hunting by Filippone, Claudia, Betsem, Edouard, Bassot, Sylviane, Tortevoye, Patricia, Froment, Alain, Fontanet, Arnaud M, Gessain, Antoine

Get full text

False submucosal rectal tumor by Brullet, Enric, Campo, Rafel, Fontanet, Mercedes, Puig, María

Get full text

Milestones On Orphan Medicinal Products Development: The 100 First Drugs for Rare Diseases Approved Throughout Europe by Pontes, C, Fontanet, J.M, Gomez-Valent, M, Rios Guillermo, J, Vives Vilagut, R, Morros, R, Martinalbo, J, Torrent-Farnell, J, Torres, F

“…According to ATC code, oncology accounted for 41.6% of indications, and endocrine and metabolic diseases for 28%…”
Get full text

Clustering of rare medical conditions based on clinical features which determine applicability of investigative designs and methods to their study by Pontes, C, Fontanet, J.M, Gomez-Valent, M, Rios Guillermo, J, Vives Vilagut, R, Morros, R, Martinalbo, J, Torrent-Farnell, J, Torres, F

“…Clinical development for new orphan drugs with a cost-efficient design and analysis, an optimal fit to needs of patients, and reliable and efficient to…”
Get full text